These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 19104497)
1. Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT. Pourgheysari B; Piper KP; McLarnon A; Arrazi J; Bruton R; Clark F; Cook M; Mahendra P; Craddock C; Moss PA Bone Marrow Transplant; 2009 Jun; 43(11):853-61. PubMed ID: 19104497 [TBL] [Abstract][Full Text] [Related]
2. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation. Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981 [TBL] [Abstract][Full Text] [Related]
3. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations. Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493 [TBL] [Abstract][Full Text] [Related]
4. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation. Eid AJ; Brown RA; Hogan WJ; Lahr BD; Eckel-Passow JE; Litzow MR; Razonable RR Transpl Infect Dis; 2009 Dec; 11(6):519-28. PubMed ID: 19744286 [TBL] [Abstract][Full Text] [Related]
5. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation. Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633 [TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern after allogeneic stem cell transplantation. Foster AE; Gottlieb DJ; Sartor M; Hertzberg MS; Bradstock KF Biol Blood Marrow Transplant; 2002; 8(9):501-11. PubMed ID: 12374455 [TBL] [Abstract][Full Text] [Related]
7. Poor CMV-specific CD8+ T central memory subset recovery at early stage post-HSCT associates with refractory and recurrent CMV reactivation. Liu J; Chang YJ; Yan CH; Xu LP; Jiang ZF; Zhang XH; Liu KY; Huang XJ J Infect; 2016 Sep; 73(3):261-70. PubMed ID: 27311748 [TBL] [Abstract][Full Text] [Related]
8. Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation. Drylewicz J; Schellens IM; Gaiser R; Nanlohy NM; Quakkelaar ED; Otten H; van Dorp S; Jacobi R; Ran L; Spijkers S; Koning D; Schuurman R; Meijer E; Pietersma FL; Kuball J; van Baarle D J Transl Med; 2016 Aug; 14(1):230. PubMed ID: 27484705 [TBL] [Abstract][Full Text] [Related]
9. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation. Widmann T; Sester U; Gärtner BC; Schubert J; Pfreundschuh M; Köhler H; Sester M PLoS One; 2008; 3(11):e3634. PubMed ID: 18982061 [TBL] [Abstract][Full Text] [Related]
10. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation. Luo XH; Huang XJ; Liu KY; Xu LP; Liu DH Biol Blood Marrow Transplant; 2010 Jul; 16(7):994-1004. PubMed ID: 20167279 [TBL] [Abstract][Full Text] [Related]
11. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients]. Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495 [TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection. Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650 [TBL] [Abstract][Full Text] [Related]
13. Timing of CMV-specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation. Espigado I; de la Cruz-Vicente F; BenMarzouk-Hidalgo OJ; Gracia-Ahufinger I; Garcia-Lozano JR; Aguilar-Guisado M; Cisneros JM; Urbano-Ispizua A; Perez-Romero P Transpl Int; 2014 Dec; 27(12):1253-62. PubMed ID: 25070273 [TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Ozdemir E; St John LS; Gillespie G; Rowland-Jones S; Champlin RE; Molldrem JJ; Komanduri KV Blood; 2002 Nov; 100(10):3690-7. PubMed ID: 12393402 [TBL] [Abstract][Full Text] [Related]
15. Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT. Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; López J; Garcia-Noblejas A; Muñoz-Cobo B; Costa E; Clari MA; Hernández-Boluda JC; Remigia MJ; Navarro D Bone Marrow Transplant; 2011 Nov; 46(11):1437-43. PubMed ID: 21243030 [TBL] [Abstract][Full Text] [Related]
16. Rapid reconstitution of CMV-specific T-cells after stem-cell transplantation. Widmann T; Sester U; Schmidt T; Gärtner BC; Schubert J; Pfreundschuh M; Sester M Eur J Haematol; 2018 Jul; 101(1):38-47. PubMed ID: 29652096 [TBL] [Abstract][Full Text] [Related]
17. Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT. Król L; Stuchlý J; Hubáček P; Keslová P; Sedláček P; Starý J; Hrušák O; Kalina T Bone Marrow Transplant; 2011 Aug; 46(8):1089-98. PubMed ID: 21057553 [TBL] [Abstract][Full Text] [Related]
19. Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation. Link CS; Eugster A; Heidenreich F; Rücker-Braun E; Schmiedgen M; Oelschlägel U; Kühn D; Dietz S; Fuchs Y; Dahl A; Domingues AM; Klesse C; Schmitz M; Ehninger G; Bornhäuser M; Schetelig J; Bonifacio E Clin Exp Immunol; 2016 Jun; 184(3):389-402. PubMed ID: 26800118 [TBL] [Abstract][Full Text] [Related]
20. Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection. Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; Garcia-Noblejas A; Clari MA; Chilet M; López J; Hernández-Boluda JC; Remigia MJ; Navarro D J Med Virol; 2010 Jul; 82(7):1208-15. PubMed ID: 20513086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]